Takaichi Cabinet 2.0 backs public-private drug R&D and extends Japan drug pricing reform 2026 to biologics via the G1 rule, moving originator prices toward biosimilar parity. What it means for Japan’s
OCX stock rises to $3.20 after hours on 23 Feb 2026 after an oversold bounce; analysis, price targets and risks for NASDAQ-listed OncoCyte
UBS downgrades Gerresheimer; quick take on the Feb 23, 2026 GRRMF analyst rating and investor implications
Pre-market volume spike in BKMINDST.BO stock on 24 Feb 2026; **volume 123,145** vs avg 180, price INR **1.81**
Bitcoin USD falls below $65K amid Trump tariff concerns. Technical analysis, price forecast, and market sentiment for BTCUSD today.
PNL.AS stock Q4: normalised EBIT rose to €79.00M, dividend cut to €0.04. Meyka AI forecast and outlook for investors
S&P 500 slips as truth social trump stir and SCOTUS tariff ruling sway risk. What it means for Canadian investors, Fed on hold odds, levels to watch, and strategy.
PEP.SW stock jumps to CHF 126.00 on a volume spike; Meyka AI flags momentum and issues model forecasts
Pre-market update on 9501.T stock at JPY 715.00 with volume 61,123,100. Meyka AI analysis and price outlook.
2349.HK stock rises 33.60% pre-market to HK$0.17 on heavy volume; read Meyka AI analysis and forecast